Clinical Trials · NCT00769548

Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Radiation Therapy Oncology Group
Enrollment
1,322
Start date
Apr 1995
Locations
See registry
Primary endpoint
Progression-free survival (Arms 1, 3 vs. Arms 2, 4)
View Gonadorelin compound reference